Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

8 Nov 2018 09:12

RNS Number : 7619G
Hongkong Land Hldgs Ltd
08 November 2018
 

To: Business Editor For immediate release

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 HONGKONG LAND HOLDINGS LIMITED

Interim Management Statement

 

8th November 2018 - Hongkong Land Holdings Limited has today issued an Interim Management Statement for the third quarter of 2018.

 

In Hong Kong, positive rental reversions continued in the Group's Central office portfolio as market supply remained tight. Vacancy declined to 0.8% at 30th September 2018, from 1.9% at 30th June 2018. The Group's Central retail portfolio remained effectively fully occupied and saw mildly positive base rental reversions. Rental reversions in the Group's Singapore office portfolio were also positive as the market there continued to improve. While vacancy increased to 2.8% at 30th September 2018 from 0.1% at 30th June 2018, it is expected to decline before the end of the year as tenants take up committed space. In Beijing, the Group's luxury retail complex, WF CENTRAL, is performing in line with expectations. The official opening of the hotel component of the development, Mandarin Oriental Wangfujing, is expected early next year.

 

In Development Properties, the Group recorded lower contracted sales in China during the third quarter due to the timing of sales launches. Sentiment in the Group's key markets remains stable, with contracted sales expected to increase in the last quarter. In the three months under review, the Group's attributable interest in contracted sales was US$154 million, compared to US$195 million last year. In the nine months to 30th September 2018, the Group's attributable interest in contracted sales was US$804 million, compared to US$896 million in the same period in 2017. In Singapore, the sales launch at Margaret Ville was successful, though market demand has subsequently moderated due to additional cooling measures introduced by the government. Sales at Parc Esta (formerly Eunosville) are expected to commence shortly. Contracted sales levels at the Group's other developments across Southeast Asia were satisfactory.

 

The Group's financial position remains strong. Net debt was US$3.7 billion at 30th September 2018 while net gearing was 10%, a moderate increase from 30th June 2018 primarily due to payments for land purchased in China.

 

Hongkong Land is a leading property investment, management and development group. The Group owns and manages more than 850,000 sq. m. of prime office and luxury retail property in key Asian cities, principally in Hong Kong, Singapore and Beijing. The Group also has a number of high quality residential, commercial and mixed-use projects under development in cities across Greater China and Southeast Asia. In Singapore, its subsidiary, MCL Land, is a well-established residential developer. Hongkong Land Holdings Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. The Group's assets and investments are managed from Hong Kong by Hongkong Land Limited. Hongkong Land is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Hongkong Land Limited

Robert Wong (852) 2842 8428

Simon Dixon (852) 2842 8101

 

Brunswick Group Limited

Karin Wong (852) 3512 5077

 

This and other Group announcements can be accessed through the Internet at 'www.hkland.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGGMUGUPRUBR
Date   Source Headline
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:57 amRNSDividend
4th Apr 201910:11 amRNSAnnual Financial Report
29th Mar 20199:15 amRNSTotal Voting Rights
27th Mar 20199:12 amRNSCirc re. Scrip Dividend Scheme
26th Mar 20199:14 amRNSDirector/PDMR Shareholding
25th Mar 20199:12 amRNSBlock listing Interim Review
20th Mar 201910:53 amRNSDirector/PDMR Shareholding
7th Mar 20199:12 amRNSDirector/PDMR Shareholding
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
31st Jan 20199:07 amRNSTotal Voting Rights
30th Jan 20199:15 amRNSNotice of 2018 Final Results
24th Jan 201911:08 amRNSDirector/PDMR Shareholding
8th Jan 201910:18 amRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 201811:32 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
7th Dec 20189:08 amRNSDirectorate Change
30th Nov 20189:16 amRNSTotal Voting Rights
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:10 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
24th Oct 201811:31 amRNSDirector/PDMR Shareholding
11th Oct 201811:52 amRNSDirector/PDMR Shareholding
10th Oct 201810:13 amRNSDirector/PDMR Shareholding
5th Oct 201810:35 amRNSAdditional Listing
2nd Oct 201811:04 amRNSForm 8.3 - Jardine Lloyd Thompson Group plc
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.